BP’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-24,687
| Closed | -$363 | – | 5 |
|
|
2022
Q2 | $363 | Hold |
24,687
| – | – | 0.21% | 5 |
|
|
2022
Q1 | $28K | Hold |
24,687
| – | – | 0.15% | 4 |
|
|
2021
Q4 | $62K | Hold |
24,687
| – | – | 0.32% | 5 |
|
|
2021
Q3 | $126K | Hold |
24,687
| – | – | 0.69% | 5 |
|
|
2021
Q2 | $205K | Hold |
24,687
| – | – | 0.01% | 576 |
|
|
2021
Q1 | $215K | Hold |
24,687
| – | – | 0.01% | 578 |
|
|
2020
Q4 | $268K | Hold |
24,687
| – | – | 0.01% | 541 |
|
|
2020
Q3 | $295K | Hold |
24,687
| – | – | 0.01% | 510 |
|
|
2020
Q2 | $396K | Buy |
+24,687
| New | +$431K | 0.01% | 516 |
|
|
2019
Q3 | – | Sell |
-14,099
| Closed | -$177K | – | 557 |
|
|
2019
Q2 | $177K | Buy |
+14,099
| New | +$181K | 0.01% | 470 |
|
|
2015
Q1 | – | Sell |
-10,393
| Closed | -$196K | – | 319 |
|
|
2014
Q4 | $196K | Hold |
10,393
| – | – | 0.01% | 307 |
|
|
2014
Q3 | $282K | Buy |
+10,393
| New | +$323K | 0.01% | 298 |
|
Other funds holding EPZM
BP's EPZM Position: Q3 2022 in Review
BP sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 24,687 shares — an estimated $363 sold.
BP first reported a position in EPZM in Q3 2014 and held it in 12 quarters. The position peaked at $396K in Q2 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- BP reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- BP sold 24,687 Epizyme, Inc shares in Q3 2022, an estimated $363.
- BP first reported a position in Epizyme, Inc in Q3 2014 and held it in 12 quarters.
- BP's Epizyme, Inc position peaked at $396K in Q2 2020.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on BP's 13F filing for Q3 2022, filed 4 Nov 2022.